Literature DB >> 29803653

No effect of sex and estrous cycle on the fear potentiated startle response in rats.

Yulong Zhao1, Elisabeth Y Bijlsma2, Monika P Verdouw1, Lucianne Groenink1.   

Abstract

The prevalence of anxiety disorders is higher in women than in men. Yet preclinical studies on anxiety are mostly performed in male subjects. This may have limited our understanding of mechanisms contributing to anxiety disorders. Since fear conditioning is considered an important factor in the etiology of anxiety disorders, the present study aimed to investigate the effect of sex and estrous cycle on conditioned fear and the anxiolytic effect of benzodiazepines in rats. We measured the fear-potentiated startle response in male and female rats during different estrous cycle stages and performed a replication study in a separate cohort. In addition, we assessed the response to diazepam (0-3.0 mg/kg IP) and chlordiazepoxide (0-10 mg/kg IP) in male and female rats in proestrous/estrous and diestrous stage. Our results showed that there were no sex differences in the expression of fear-potentiated startle. The estrous cycle also did not affect the fear-potentiated startle response. In addition, male and female rats did not differ in their fear-potentiated startle response following treatment with either diazepam or chlordiazepoxide. In conclusion, the current study shows that male and female rats do not differ in their conditioned fear response and the responsiveness to benzodiazepines. The results further indicate that conditioned fear-related processes are not affected by gonadal hormone fluctuations in this paradigm. These findings may suggest that the higher prevalence of anxiety disorders in women more likely results from differences in responding to previous experiences or differences in other predisposing factors, rather than differences in conditioned fear per se.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chlordiazepoxide; Diazepam; Estrous cycle; Fear-potentiated startle test; Female rats; Sex differences

Mesh:

Substances:

Year:  2018        PMID: 29803653     DOI: 10.1016/j.bbr.2018.05.022

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABAA receptors.

Authors:  Zhiqiang Meng; Lais F Berro; Eileen K Sawyer; Daniela Rüedi-Bettschen; Jemma E Cook; Guanguan Li; Donna M Platt; James M Cook; James K Rowlett
Journal:  J Psychopharmacol       Date:  2019-10-31       Impact factor: 4.153

2.  Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test.

Authors:  Yulong Zhao; Elisabeth Y Bijlsma; Freija Ter Heegde; Monika P Verdouw; J Garssen; Adrian Newman-Tancredi; Lucianne Groenink
Journal:  Psychopharmacology (Berl)       Date:  2018-12-12       Impact factor: 4.530

3.  Endocannabinoids and Fear-Related Behavior in Mice Selectively Bred for High or Low Alcohol Preference.

Authors:  Aaron M Kirchhoff; Eric L Barker; Julia A Chester
Journal:  Brain Sci       Date:  2019-09-26

4.  Comparison of cannabidiol to citalopram in targeting fear memory in female mice.

Authors:  Zackary T Montoya; Amy L Uhernik; Jeffrey P Smith
Journal:  J Cannabis Res       Date:  2020-12-11

Review 5.  Effect of Estrous Cycle on Behavior of Females in Rodent Tests of Anxiety.

Authors:  Thelma A Lovick; Hélio Zangrossi
Journal:  Front Psychiatry       Date:  2021-08-31       Impact factor: 4.157

6.  Hippocampal neurogenesis mediates sex-specific effects of social isolation and exercise on fear extinction in adolescence.

Authors:  Katherine D Drummond; Michelle L Waring; Geoffrey J Faulkner; Marnie E Blewitt; Christina J Perry; Jee Hyun Kim
Journal:  Neurobiol Stress       Date:  2021-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.